XBI ETF
State Street SPDR S&P Biotech ETF
XBI ETF Overview
XBI ETF (State Street SPDR S&P Biotech ETF) is managed by State Street Investment Management with $11.51B in net assets. XBI expense ratio is 0.35%, holding 160 positions across sectors including Health Care, Financials. Inception date: 2006-01-31.
XBI performance shows a YTD return of 21.10%. The 1-year return is 72.47% and the 5-year return is 3.69%. XBI dividend yield stands at 0.39%, paid quarterly.
XBI top holdings include Apogee Therapeutics Inc (1.6%), Oruka Therapeutics Inc Orka (1.5%), Twist Bioscience Corp. (1.4%), Dianthus Therapeutics Inc (1.4%), Spyre Therapeutics Inc (1.4%). Go to all XBI holdings, XBI sectors, or XBI dividends.
XBI can be compared against other funds. Use XBI overlap to find shared positions, or XBI vs another fund for a side-by-side view. XBI alternatives are available via the screener, along with tax-loss harvesting opportunities.